Connection

David Taber to Carcinoma, Renal Cell

Back to Details
This is a "connection" page, showing publications David Taber has written about Carcinoma, Renal Cell.
David Taber
Connection Strength
0.039
Carcinoma, Renal Cell
  1. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol. 2000 Jan; 18(2):371-5.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.